German Cannabis Medication Law Sparks Allegations of Political Influence and Corporate Gain

Parliamentary approval of new regulations for cannabis-based painkillers heavily benefits a Munich manufacturer, with investigations suggesting potential executive pressure during the approval process.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

der-spiegelGerman10h ago

Cannabis-Investitionen: Profitieren CSU-Spender von neuer Cannabis-Regelung?

Der Bundestag hat eine neue Regelung zu Cannabis-Medikamenten beschlossen. Der wohl größte Profiteur ist ein Münchner Hersteller. SPIEGEL-Recherchen legen nahe, dass es bei der Zulassung seines Schmerzmittels Druck von oben gab.

Read full article →

PERSPECTA

PERSPECTA

German Cannabis Medication Law Sparks Allegations of Political Influence and Corporate Gain

Sources

Cannabis-Investitionen: Profitieren CSU-Spender von neuer Cannabis-Regelung?

Related Stories

Federal Judge Blocks Pentagon Blacklisting of AI Firm Anthropic

Nigerian Court Orders NDLEA to Produce Detained Celebrity KC Luxury

Trump Orders Lake Ontario Renamed as 'Lake America', Sparking Canadian Backlash

US Court Denies Bail to Tate Brothers During Extradition Proceedings

PERSPECTA